drugset / Trial / NCT04074408
Intracavitary Injection of hUMSCs in Acute Basal Ganglia Hematoma After Stereotactic Aspiration
Phase 2
Unknown
100 enrolled
Second Affiliated Hospital, School of Medicine, Zhejiang University
First Affiliated Hospital of Fujian Medical University · collabJinhua Hospital, School of Medicine, Zhejiang University · collabTaizhou Hospital · collabThe First Affiliated Hospital, University of Science and Technology of China · collabZhejiang University · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
A study to examine the safety and potential effectiveness of human umbilical cord mesenchymal stem cells (hUMSCs) in adults who have suffered spontaneous cerebral hemorrhage in basal ganglia. The hypothesis is that hUMSCs will be safe and can improve neurological function after intracerebral hemorrhage so that improve the prognosis of patients.
Timeline
- Start
- 2020-05
- Primary completion
- 2022-11
- Completion
- 2023-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HUMSCs | Cell therapy | — | Other |